Sort
21,453 grants matching “tuberculosis”
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
$3,019,448Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI
The Genome Analysis Core
$3,017,558Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$3,015,851Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2016 · AI
International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)
$3,000,683Matthias Egger · Universitat Bern · U01 · FY2019 · AI
A Low Cost Integrated Method for Isolation of M. Tuberculosis DNA from Raw Sputum
$2,999,954Rebecca Holmberg · Akonni Biosystems, Inc. · N44 · FY2019 · AI
Inhaled Delivery of Clofazimine - A High Efficiency, Flow Independent, Targeted, Low Cost DPI
$2,999,221John Koleng · Via Therapeutics, Llc · N44 · FY2020 · AI
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections-A5407 Third Supplement
$2,991,790Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT
$2,986,884University Of Alabama At Birmingham · U01 · FY2004 · AI
Diagnostic MDR- and XDR-TB PCR TruArray
$2,985,932Darrell P Chandler · Akonni Biosystems, Inc. · RC3 · FY2010 · AI
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$2,982,118L Masae Kawamura · San Francisco Department Of Public Health · U52 · FY2007 · PS
IeDEA Asia-Pacific Research Collaboration
$2,971,207Annette H Sohn · Foundation For Aids Research · U01 · FY2023 · AI
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
$2,971,049Megan B Murray · Harvard Medical School · U19 · FY2022 · AI
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT
$2,964,833University Of Alabama At Birmingham · U01 · FY2003 · AI
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)
$2,964,560Timothy T Stedman · American Type Culture Collection · N01 · FY2012 · AI
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$2,955,783Linda-Gail Bekker · University Of Cape Town · UM1 · FY2021 · AI
Clinical Trials Units for NIAID Networks (UM1)
$2,952,539Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2014 · AI
University of Pennsylvania HIV Clinical Trials Unit
$2,946,326Ian Frank · University Of Pennsylvania · UM1 · FY2024 · AI
PHRU-Setshaba Clinical Trials Unit
$2,946,297Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2025 · AI
Understanding resistance and tolerance to nitroimidazoles in Mycobacterium tuberculosis
$2,944,529Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$2,943,796Alan Sher · Niaid Extramural Activities · Z01 · FY2007 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,942,898Pablo Tebas · University Of Pennsylvania · UM1 · FY2019 · AI
Vanderbilt HIV Clinical Trials Unit
$2,941,559David W Haas · Vanderbilt University Medical Center · UM1 · FY2019 · AI
Metabolic factors that control the spectrum of human tuberculosis
$2,941,042David Branch Moody · Brigham And Women'S Hospital · U19 · FY2020 · AI
TB Clinical Diagnostics Research Consortium
$2,939,729Jerrold J. Ellner · Johns Hopkins University · N01 · FY2012 · AI
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
$2,936,284Megan B Murray · Harvard Medical School · U19 · FY2020 · AI